Novavax Inc.

NASDAQ: NVAX · Real-Time Price · USD
9.70
0.12 (1.25%)
At close: Aug 18, 2025, 3:59 PM
9.85
1.55%
After-hours: Aug 18, 2025, 06:33 PM EDT

Novavax Revenue

Novavax reported an annual revenue of $682.16M, reflecting a 22.61% growth. For the quarter ending June 30, 2025, Novavax generated $239.24M in revenue.
Revenue (ttm)
682.16M
Revenue Growth
22.61%
Price / Sales Ratio
1.79
Revenue / Employee
716.56K
Employees
952
Market Cap
1.58B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 682.16M +22.61%
Dec 31, 2023 556.38M -65.20%
Dec 31, 2022 1.6B +39.49%
Dec 31, 2021 1.15B +141.02%
Dec 31, 2020 475.6M +2448.48%
Dec 31, 2019 18.66M -45.57%
Dec 31, 2018 34.29M +9.98%
Dec 31, 2017 31.18M +103.06%
Dec 31, 2016 15.35M -57.65%
Dec 31, 2015 36.25M +18.24%
Dec 31, 2014 30.66M +46.59%
Dec 31, 2013 20.91M -5.26%
Dec 31, 2012 22.08M +50.30%
Dec 31, 2011 14.69M +4182.22%
Dec 31, 2010 343K +5.54%
Dec 31, 2009 325K -69.45%
Dec 31, 2008 1.06M -29.68%
Dec 31, 2007 1.51M -67.69%
Dec 31, 2006 4.68M -36.61%
Dec 31, 2005 7.39M -10.56%
Dec 31, 2004 8.26M -29.91%
Dec 31, 2003 11.79M -21.46%
Dec 31, 2002 15.01M -37.65%
Dec 31, 2001 24.07M +872.36%
Dec 31, 2000 2.48M +106.25%
Dec 31, 1999 1.2M +71.43%
Dec 31, 1998 700K +40.00%
Dec 31, 1997 500K +400.00%
Dec 31, 1996 100K n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.